# Inhaled Isopropyl Alcohol for Treatment of Nausea

> **NCT05418244** · PHASE2,PHASE3 · RECRUITING · sponsor: **State University of New York at Buffalo** · enrollment: 84 (estimated)

## Conditions studied

- Vomiting
- Nausea
- Children, Only

## Interventions

- **OTHER:** Inhaled Isopropyl Alcohol
- **DRUG:** Oral Ondansetron
- **OTHER:** Inhaled Placebo

## Key facts

- **NCT ID:** NCT05418244
- **Lead sponsor:** State University of New York at Buffalo
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-04-20
- **Primary completion:** 2026-06-30
- **Final completion:** 2026-06-30
- **Target enrollment:** 84 (ESTIMATED)
- **Last updated:** 2025-10-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05418244

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05418244, "Inhaled Isopropyl Alcohol for Treatment of Nausea". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05418244. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*